Key result
Dynapenia and sarcopenia linked to markedly lower peak VO2 in adolescent Fontan patients.
Why the study?
Although skeletal muscle acts as a secondary pump in passive Fontan circulation, the prevalence and clinical significance of muscle health abnormalities like dynapenia and sarcopenia remain poorly defined in adolescent Fontan patients.
Does stratification of muscle health abnormalities (dynapenia and sarcopenia) via handgrip strength and DXA identify reduced exercise capacity and higher risk of Fontan-associated complications in adolescent Fontan patients?
Cross-Sectional (n=43)
No
Does stratification of muscle health abnormalities (dynapenia and sarcopenia) via handgrip strength and DXA identify reduced exercise capacity and higher risk of Fontan-associated complications in adolescent Fontan patients?
Muscle health abnormalities affect nearly one-third of adolescent Fontan patients, and isolated muscle weakness (dynapenia) is strongly associated with reduced exercise capacity and a 50% rate of Fontan-associated complications despite normal resting hemodynamics, supporting routine handgrip strength screening.
Answers are grounded in this paper and cite their sources.
Handgrip screening may aid risk stratification in Fontan adolescents; leaves open whether sarcopenia-targeted interventions improve peak VO2.
Background Skeletal muscle acts as a secondary pump in passive Fontan circulation. However, the prevalence and clinical significance of muscle health abnormalities, such as dynapenia and sarcopenia, remain poorly defined in adolescent Fontan patients. Methods We evaluated 43 adolescent Fontan patients (median age: 11.8 years). Skeletal muscle mass index via DXA and handgrip strength (HGS) were expressed as Z-scores to classify patients into three phenotypes: Normal (N), Dynapenia (D: HGS Z-score < -2 SD, preserved mass), and Sarcopenia (S: both < -2 SD). Peak \(\:{VO}₂\) was defined as the primary outcome, while resting hemodynamics, biomarkers, and Fontan-associated complications were secondary outcomes. Results The prevalence of dynapenia and sarcopenia was 19% (n = 8) and 12% (n = 5), respectively (Normal: 70%, n = 30). Peak \(\:{VO}₂\) showed a significant stepwise decline across the N, D, and S groups (89.6%, 73.8%, and 48.8% of predicted, respectively; \(\:p<0.01\)). Resting cardiac index, central venous pressure, ejection fraction, and BNP showed no significant differences between the N and D groups. However, severe complications (e.g., protein-losing enteropathy) were markedly higher in the D (50%) and S (80%) groups than in the N group (10%; \(\:p<0.01\)). Conclusions Muscle health abnormalities affect nearly one-third of adolescent Fontan patients. Notably, patients with dynapenia may exhibit a high incidence of complications despite normal resting hemodynamics and laboratory data. These findings suggest a cardiac-skeletal muscle crosstalk. Thus, routine handgrip strength measurement serves as a simple, practical tool to identify high-risk patients during routine follow-up.
No takes yet. Share an insight, caveat, or question.
Higashi et al. (2026) conducted a cross-sectional in Fontan circulation in adolescents (n=43). Dynapenia (handgrip strength Z-score < -2.0 SD with preserved muscle mass) and Sarcopenia (both < -2.0 SD) vs. Normal muscle health (handgrip strength and skeletal muscle mass index Z-scores >= -2.0 SD) was evaluated on Exercise capacity (%predicted peak VO2) (p=<0.01). Dynapenia and sarcopenia were associated with significantly lower %predicted peak VO2 (73.8% and 48.8% vs 89.6% in normal muscle group; p<0.01) in adolescent Fontan patients.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: